Francés Rubén, Benlloch Susana, Zapater Pedro, González José M, Lozano Beatriz, Muñoz Carlos, Pascual Sonia, Casellas Juan A, Uceda Francisco, Palazón José M, Carnicer Fernando, Pérez-Mateo Miguel, Such José
Unidad Hepática Sección de Inmunología, Alicante, Spain.
Hepatology. 2004 Feb;39(2):484-91. doi: 10.1002/hep.20055.
Bacterial translocation is currently considered the main pathogenic mechanism leading to spontaneous bacterial peritonitis in patients with advanced cirrhosis and ascites. However, to the authors' knowledge there is no information regarding the characteristics of this process in humans. The goals of the current study were to pursue partially identified bacterial DNA in blood (what the authors consider molecular evidence of bacterial translocation) through its relative quantification in a 72-hour study period by using real-time polymerase chain reaction (PCR). A consecutive series of 17 patients with advanced cirrhosis and culture-negative, nonneutrocytic ascites were studied. Therapeutic paracentesis was performed at the time of admission, and blood samples were obtained at baseline and every 8 hours in a 3-day period. Bacterial DNA was detected by a PCR-based method, relatively quantified by real-time PCR, and identified by automated nucleotide sequencing. Seven of 17 patients demonstrated the simultaneous presence of bacterial DNA in blood and ascitic fluid at the time of admission. After therapeutic paracentesis was performed, bacterial DNA persisted in the blood for a minimum of 24 hours, and was reported to last as long as 72 hours in some patients. In addition, different patterns of bacterial DNA appearance and clearance from the blood were identified. The nucleotide sequencing process demonstrated that bacteria detected in the first sample were identical to those noted in subsequent detections over time. In conclusion, bacterial translocation is a single-species, dynamic process that appears to develop in a subgroup of patients with advanced cirrhosis.
细菌移位目前被认为是导致晚期肝硬化和腹水患者发生自发性细菌性腹膜炎的主要致病机制。然而,据作者所知,尚无关于该过程在人体中的特征的信息。本研究的目的是通过使用实时聚合酶链反应(PCR)在72小时的研究期内对血液中部分已鉴定的细菌DNA进行相对定量,来追踪细菌移位的分子证据。对17例晚期肝硬化且腹水培养阴性、非中性粒细胞性腹水的患者进行了连续研究。入院时进行治疗性腹腔穿刺术,并在基线时以及在3天内每8小时采集血样。通过基于PCR的方法检测细菌DNA,通过实时PCR进行相对定量,并通过自动核苷酸测序进行鉴定。17例患者中有7例在入院时血液和腹水中同时存在细菌DNA。治疗性腹腔穿刺术后,细菌DNA在血液中至少持续存在24小时,据报道在一些患者中可持续长达72小时。此外,还确定了细菌DNA在血液中出现和清除的不同模式。核苷酸测序过程表明,在第一个样本中检测到的细菌与随时间在后续检测中发现的细菌相同。总之,细菌移位是一个单一物种的动态过程,似乎在晚期肝硬化患者的一个亚组中发生。